HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis

Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically be...

Full description

Bibliographic Details
Main Authors: Elvira Favoino, Livio Urso, Alessandra Serafino, Francesca Misceo, Giacomo Catacchio, Marcella Prete, Federico Perosa
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/14/3006
id doaj-cb8b788e7dfa4af298b99f8c5973fe3d
record_format Article
spelling doaj-cb8b788e7dfa4af298b99f8c5973fe3d2021-07-23T13:47:44ZengMDPI AGJournal of Clinical Medicine2077-03832021-07-01103006300610.3390/jcm10143006HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated SpondyloarthritisElvira Favoino0Livio Urso1Alessandra Serafino2Francesca Misceo3Giacomo Catacchio4Marcella Prete5Federico Perosa6Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalyDepartment of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, ItalySpondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically been the SpA subgroup with one of the strongest, best-proven associations with HLA-B27. The remaining SpA subgroups, namely psoriatic arthritis (PsA), inflammatory bowel diseases-associated arthritis/spondylitis, reactive arthritis, and undifferentiated SpA (uSpA), have also been associated with HLA allotypes other than HLA-B27. In this retrospective study, we analyzed the association between the HLA class I and II haplotypes and the susceptibility to enthesitis and/or arthritis (E/A). Special attention was paid to E/A responding to disease-modifying antirheumatic drugs (DMARDs) not fulfilling ASAS classification criteria (ASAS<sup>−</sup>), as compared to ASAS<sup>+</sup> forms including PsA and uSpA. The whole E/A group showed significant independent associations with HLA-A28(68), B27, Cw3, Cw12, and DQ1; taken singly, PsA was associated with HLA-B27 and DQ1, uSpA with HLA-B16(38,39) and B27, and E/A ASAS<sup>−</sup> with HLA-A28(68), Cw8, and Cw12. This study identified novel risk HLA allotypes for different SpA subgroups in an Italian population. HLA typing could aid the diagnosis and treatment of E/A subgroups, including DMARDS-responsive forms not fulfilling ASAS classification criteria.https://www.mdpi.com/2077-0383/10/14/3006spondyloarthritishuman leukocyte antigenundifferentiated enthesitis and/or arthritisASAS classification criteriaclinical management
collection DOAJ
language English
format Article
sources DOAJ
author Elvira Favoino
Livio Urso
Alessandra Serafino
Francesca Misceo
Giacomo Catacchio
Marcella Prete
Federico Perosa
spellingShingle Elvira Favoino
Livio Urso
Alessandra Serafino
Francesca Misceo
Giacomo Catacchio
Marcella Prete
Federico Perosa
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
Journal of Clinical Medicine
spondyloarthritis
human leukocyte antigen
undifferentiated enthesitis and/or arthritis
ASAS classification criteria
clinical management
author_facet Elvira Favoino
Livio Urso
Alessandra Serafino
Francesca Misceo
Giacomo Catacchio
Marcella Prete
Federico Perosa
author_sort Elvira Favoino
title HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
title_short HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
title_full HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
title_fullStr HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
title_full_unstemmed HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
title_sort hla allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling asas criteria: comparison with psoriatic and undifferentiated spondyloarthritis
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-07-01
description Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically been the SpA subgroup with one of the strongest, best-proven associations with HLA-B27. The remaining SpA subgroups, namely psoriatic arthritis (PsA), inflammatory bowel diseases-associated arthritis/spondylitis, reactive arthritis, and undifferentiated SpA (uSpA), have also been associated with HLA allotypes other than HLA-B27. In this retrospective study, we analyzed the association between the HLA class I and II haplotypes and the susceptibility to enthesitis and/or arthritis (E/A). Special attention was paid to E/A responding to disease-modifying antirheumatic drugs (DMARDs) not fulfilling ASAS classification criteria (ASAS<sup>−</sup>), as compared to ASAS<sup>+</sup> forms including PsA and uSpA. The whole E/A group showed significant independent associations with HLA-A28(68), B27, Cw3, Cw12, and DQ1; taken singly, PsA was associated with HLA-B27 and DQ1, uSpA with HLA-B16(38,39) and B27, and E/A ASAS<sup>−</sup> with HLA-A28(68), Cw8, and Cw12. This study identified novel risk HLA allotypes for different SpA subgroups in an Italian population. HLA typing could aid the diagnosis and treatment of E/A subgroups, including DMARDS-responsive forms not fulfilling ASAS classification criteria.
topic spondyloarthritis
human leukocyte antigen
undifferentiated enthesitis and/or arthritis
ASAS classification criteria
clinical management
url https://www.mdpi.com/2077-0383/10/14/3006
work_keys_str_mv AT elvirafavoino hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT liviourso hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT alessandraserafino hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT francescamisceo hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT giacomocatacchio hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT marcellaprete hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
AT federicoperosa hlaalleleprevalenceindiseasemodifyingantirheumaticdrugsresponsiveenthesitisandorarthritisnotfulfillingasascriteriacomparisonwithpsoriaticandundifferentiatedspondyloarthritis
_version_ 1721287714737750016